Microarray Strategies for Multiplexed Immunochemical Analysis

Programa de Doctorat en Biotecnologia / Tesi realitzada a l'Institut de Química Avançada de Catalunya (IQAC-CSIC)

Detalhes bibliográficos
Autor: Guercetti, Julian
Formato: tesis doctoral
Estado:Versión publicada
Fecha de publicación:2023
País:España
Recursos:CBUC, CESCA
Repositorio:TDR. Tesis Doctorales en Red
OAI Identifier:oai:www.tdx.cat:10803/690716
Acesso em linha:http://hdl.handle.net/10803/690716
Access Level:acceso abierto
Palavra-chave:Microarrays
Protein microarrays
Immunologia
Inmunología
Immunology
Biosensors
Biosensores
Ciències de la Salut
577
id ES_e1cd1f09e2247b01dc0a6581c297ccb3
oai_identifier_str oai:www.tdx.cat:10803/690716
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Microarray Strategies for Multiplexed Immunochemical Analysis
title Microarray Strategies for Multiplexed Immunochemical Analysis
spellingShingle Microarray Strategies for Multiplexed Immunochemical Analysis
Guercetti, Julian
Microarrays
Protein microarrays
Immunologia
Inmunología
Immunology
Biosensors
Biosensores
Ciències de la Salut
577
title_short Microarray Strategies for Multiplexed Immunochemical Analysis
title_full Microarray Strategies for Multiplexed Immunochemical Analysis
title_fullStr Microarray Strategies for Multiplexed Immunochemical Analysis
title_full_unstemmed Microarray Strategies for Multiplexed Immunochemical Analysis
title_sort Microarray Strategies for Multiplexed Immunochemical Analysis
dc.creator.none.fl_str_mv Guercetti, Julian
author Guercetti, Julian
author_facet Guercetti, Julian
author_role author
dc.contributor.none.fl_str_mv Marco Colás, Ma. Pilar
Salvador Vico, Juan Pablo
Baldomà Llavinés, Laura
Universitat de Barcelona. Facultat de Farmàcia i Ciències de l'Alimentació
dc.subject.none.fl_str_mv Microarrays
Protein microarrays
Immunologia
Inmunología
Immunology
Biosensors
Biosensores
Ciències de la Salut
577
topic Microarrays
Protein microarrays
Immunologia
Inmunología
Immunology
Biosensors
Biosensores
Ciències de la Salut
577
description Programa de Doctorat en Biotecnologia / Tesi realitzada a l'Institut de Química Avançada de Catalunya (IQAC-CSIC)
publishDate 2023
dc.date.none.fl_str_mv 2023
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/doctoralThesis
info:eu-repo/semantics/publishedVersion
format doctoralThesis
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10803/690716
url http://hdl.handle.net/10803/690716
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 404 p.
application/pdf
dc.publisher.none.fl_str_mv Universitat de Barcelona
publisher.none.fl_str_mv Universitat de Barcelona
dc.source.none.fl_str_mv TDX (Tesis Doctorals en Xarxa)
reponame:TDR. Tesis Doctorales en Red
instname:CBUC, CESCA
instname_str CBUC, CESCA
reponame_str TDR. Tesis Doctorales en Red
collection TDR. Tesis Doctorales en Red
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422326215344128
spelling Microarray Strategies for Multiplexed Immunochemical AnalysisGuercetti, JulianMicroarraysProtein microarraysImmunologiaInmunologíaImmunologyBiosensorsBiosensoresCiències de la Salut577Programa de Doctorat en Biotecnologia / Tesi realitzada a l'Institut de Química Avançada de Catalunya (IQAC-CSIC)[eng] The current doctoral thesis titled “Microarray Strategies for Multiplexed Immunochemical Analysis” was carried out in the context of two research projects, expecting to develop multiplexed ligand-binding assays under microarray format for universal applications. On one side, framed by the FoodSmartphone project (ITN-Marie Curie Actions Horizon 2020) the PART I of the thesis was dedicated to generate a multiplexed and high-throughput screening platform based on DNA-directed immobilization (DDI) strategies for the detection of antibiotic residues in cow’s milk according to EU regulations. For this, three class selective monoclonal antibodies, in-house produced, targeting fluoroquinolones, sulfonamides and tylosin were utilized in an indirect competitive immunoassay format, achieving limits of detection in the order of ppb’s. The use of oligonucleotide strains conjugated to hapten molecules allowed site encoding the signal of each hapten-antibody pair, using a fluorescently labelled secondary antibodies for detection. After assay characterization a pre-validation study was performed with the idea to evaluate the application of the novel platform in blind samples, allowing the identification of at least 18 veterinary residues according to regulatory limits and with a sample processing capacity of 180 samples per run in less than 90 minutes. As part of the same project, the implementation of the immunoreagents utilized in the DDI microarray was evaluated in a portable and miniaturized imaging surface plasmon resonance (iSPR) sensor combining smartphone readout system as a proof of concept. It was possible to evidence the binding between one of the monoclonal antibodies to the respective hapten molecule in a label free configuration, for a promising transition towards more user-friendly and cost-effective bioanalytical tools coupled to smartphone systems. On the other hand, the PART II of the thesis was carried out in the context of the PoC4CoV project, attempting to produce point-of-care tests for the rapid detection of SARS-CoV-2 at different levels. Through this work the manufacture of a microarray chip based on SARS-CoV-2 peptides and proteins for personalized immunodiagnostic of COVID-19 was conducted. Initially, a rational design of potential immunogenic linear peptides (15-mer) derived from S and N proteins of the virus was proposed. A total of 28 peptide sequences were selected through computational models and immunogenicity studies and then synthesized also including peptides derived from variants of concern. After platform optimization studies, a multiplexed and high- throughput hybrid microarray chip constituted by full length viral proteins and the selected sequences defined the so called Immuno-μSARS2 chip. This microarray allowed simultaneous IgG and IgM personalized profiling against the selected panel of epitopes with minimum sample requirements, offering an affordable and easy to implement immunodiagnostic tool. The Immuno-μSARS2 chip was successfully implemented in more than 750 human serum samples, achieving a 98 % of clinical sensitivity and 91 % of clinical specificity respecting to the RT-PCR. To extend the potential use of the chip, the integration of artificial intelligence was combined with sample analysis to define immunological signatures based on IgG response disease severity prediction using samples classified according to COVID-19 clinical outcomes. Our platform was able to discriminate with an 81 % of accuracy patients progressing towards irreversible disease condition (Exitus), followed by 70 % accuracy those patients admitted to ICU and with a discriminate in a 66 % those requiring hospitalization, from asymptomatic disease course. At the same time, a few peptide sequences were found as promising immunodiagnostic elements that could potentially replace the use of full-length proteins to generate affordable tests in the future. The methodology applied over this experimental section can be easily translated into other viruses or diseases expecting to improve diagnostic and prognostic performance.Universitat de BarcelonaMarco Colás, Ma. PilarSalvador Vico, Juan PabloBaldomà Llavinés, LauraUniversitat de Barcelona. Facultat de Farmàcia i Ciències de l'Alimentació202420242023info:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersion404 p.application/pdfhttp://hdl.handle.net/10803/690716TDX (Tesis Doctorals en Xarxa)reponame:TDR. Tesis Doctorales en Redinstname:CBUC, CESCAInglésADVERTIMENT. Tots els drets reservats. L'accés als continguts d'aquesta tesi doctoral i la seva utilització ha de respectar els drets de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials d'investigació i docència en els termes establerts a l'art. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix l'autorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No s'autoritza la seva reproducció o altres formes d'explotació efectuades amb finalitats de lucre ni la seva comunicació pública des d'un lloc aliè al servei TDX. Tampoc s'autoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs.info:eu-repo/semantics/openAccessoai:www.tdx.cat:10803/6907162026-06-14T12:46:07Z
score 15,198674

Registos relacionados